🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Phase 1b

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer NCT07539155Phase 1, Phase 21 site📍 Little Rock University of Arkansas · Tests: Intratumoral MMR Injection A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer NCT06385080Phase 1, Phase 256 sites📍 La Jolla📍 Aurora📍 New Haven Janssen Research & Development, LLC · Tests: Amivantamab, Pembrolizumab, Paclitaxel, Carboplatin Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma NCT06229496Phase 13 sites📍 Chiayi City📍 Kaohsiung City📍 Taoyuan Chang Gung Memorial Hospital · Tests: Gemcitabine 800mg/m2 + Nab-paclitaxel 100mg/m2 + S-1 (dose according to BSA), Gemcitabine 800mg/m2 + Nab-paclitaxel 125… 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer NCT07145177Phase 11 site📍 San Francisco University of California, San Francisco · Tests: 177Lu-PSMA-617, Ablation, Trans-arterial chemoembolization (TACE), Positron Emission Tomography (PET)/Computerized tomo… Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) NCT07215650Phase 110 sites📍 Fuzhou📍 Guangzhou📍 Guangzhou Candid Therapeutics · Tests: Cizutamig A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD NCT06405633Phase 1, Phase 29 sites📍 Fitzroy📍 Halifax📍 Toronto Wave Life Sciences USA, Inc. · Tests: WVE-006 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Phase 1 Study of CLR 125 in Triple Negative Breast Cancer NCT07311993Phase 14 sites📍 Jacksonville📍 Glen Burnie📍 Rochester Cellectar Biosciences, Inc. · Tests: Iopofosine I 131, CLR 125 A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites📍 Newport Beach📍 Stanford📍 Miami Eli Lilly and Company · Tests: LY4337713 A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria NCT07241234Phase 15 sites📍 Indianapolis📍 Pittsburgh📍 Dallas Agios Pharmaceuticals, Inc. · Tests: AG-181 A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 NCT06240728Phase 18 sites📍 Baltimore📍 Boston📍 The Bronx NextPoint Therapeutics, Inc. · Tests: NPX887 Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma NCT07333430Phase 11 site📍 Jerusalem Hadassah Medical Organization · Tests: Naive HBI0101 CAR-T Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases NCT07614477Phase 22 sites📍 Beijing📍 Tianjin Everest Medicines (China) Co.,Ltd. · Tests: EVER001 A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors NCT06764771Phase 18 sites📍 Hackensack📍 Allentown📍 Germantown Bristol-Myers Squibb · Tests: BMS-986488, Adagrasib, Cetuximab, Nivolumab A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms NCT07849231Phase 136 sites📍 Birmingham📍 Gilbert📍 Duarte Damora Therapeutics · Tests: DMR-001, Ruxolitinib NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma NCT07052305Phase 11 site📍 St Louis Washington University School of Medicine · Tests: NT-I7, CAR T-cell therapy A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions NCT07734064Phase 14 sites📍 Phoenix📍 Southaven📍 Cincinnati Astellas Institute for Regenerative Medicine · Tests: ASP2020 A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer NCT06457919Phase 1, Phase 212 sites📍 New Haven📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: Tinengotinib, abiraterone acetate with prednisone, Enzalutamide A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma NCT07688187Phase 11 site📍 Omaha PeptiDream Inc. · Tests: PD-32766D (a Copper-64 [64Cu] labeled peptide), PD-32766T (an Actinium-225 [225Ac] labeled peptide) Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites📍 Scottsdale📍 Denver📍 Nashville Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of… A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites📍 Aurora📍 Lake Mary📍 Lebanon 7 Hills Pharma, LLC · Tests: Alintegimod, Ipilimumab, Nivolumab A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia NCT05865535Phase 112 sites📍 Beverly Hills📍 Lakewood📍 Newport Beach AVEO Pharmaceuticals, Inc. · Tests: AV-380 A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress NCT06658535Phase 12 sites📍 Edmonton📍 Montreal NuvOx LLC · Tests: dodecafluoropentane (0.025 mL/kg), dodecafluoropentane (0.032 mL/kg), dodecafluoropentane (0.050 mL/kg) A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis NCT07250750Phase 1, Phase 225 sites📍 Altamonte Springs📍 Boca Raton📍 Naples ImmunAbs Inc. · Tests: IM-101 Part A, Placebo Part A, IM-101 Part B, Placebo Part B Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors NCT05784688Phase 1, Phase 211 sites📍 San Antonio📍 Tyler📍 Spokane TiumBio Co., Ltd. · Tests: TU2218 + KEYTRUDA® (Pembrolizumab) BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079Phase 117 sites📍 Los Angeles📍 Sacramento📍 San Diego TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · Tests: BBO-11818, Pembrolizumab, Platinum chemotherapy (cisplatin or carboplatin), Pemetrexed, Cetuximab Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS NCT06533761Phase 112 sites📍 Duarte📍 Aurora📍 Tampa Stelexis BioSciences · Tests: Eganelisib, Eganelisib in combination with cytarabine, Eganelisib in combination with azacitidine, Azacitadine (AZA) Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients NCT05532696Phase 1, Phase 25 sites📍 Taichung📍 Tainan📍 Taipei Anbogen Therapeutics, Inc. · Tests: ABT-101 A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) NCT06521554Phase 121 sites📍 Irvine📍 Sacramento📍 Stanford Nuvalent Inc. · Tests: NVL-330 Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa NCT06591793Phase 1, Phase 23 sites📍 Naples📍 London📍 London AAVantgarde Bio Srl · Tests: AAVB-081
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy